Journal of Pharmaceutical Investigation

The Korean Society of Pharmaceutical Sciences and Technology (한국약제학회)
권호 표지
DOI QR코드

DOI QR Code

Preparation of Tenoxicam Salt with Ethanolamine to Enhance the Percutaneous Absorption

테녹시캄의 피부 흡수율을 증진시키기 위한 에탄올아민염의 제조

  • Published : 2006.06.21
Download PDF
⟨ Previous Next ⟩

Abstract

The aim of this work was to prepare tenoxicam-ethanolamine salt with improved physicochemical properties for transdermal application. Tenoxicam-ethanolamine salt was prepared in methylene chloride and its physicochemical properties were investigated by DSC and FT-lR. The broad peak of tenoxicam around 3600-3200 $cm^-1$ was shifted to lower wavenumber and more broadened. The characteristic endothermic melting peak of tenoxicam appeared at $223^{\circ}C$. The melting peak of tenoxicam-ethanolamine salt was shifted to $159^{\circ}C$. In contrast to relatively small difference in the partition coefficients of tenoxicam and the tenoxicam-ethanolamine salt, large difference in aqueous solubility was observed. $Crovol^{\circledR}$ PK4O (PEG-12 palm kernel glycerides) provided the highest skin flux for both compounds. The order of the enhancing effect of the various vehicles tested was similar for tenoxicam and tenoxicam-ethanolamine salt, which indicated that their enhancing mechanism for tenoxicam and tenoxicam-ethanolamine salt is similar. Tenoxicam-ethanolamine salt had a higher skin flux than tenoxicam by 1.2- to 31.7-fold, depending on the vehicles used. It is suggested that the vehicles with medium HLB value, 1 double bond, and lower ethylene oxide chain length have a better ability to modify the permeability of the stratum corneum and to promote the effective penetration of tenoxicam and tenoxicam-ethanolamine salt.

Keywords

References

  1. P.A. Insel, Analgesic-antipyretic and anti-inflammatory agents and drugs employed in the treatment of gout: In Goodman & Gilmans the pharmacological basis of therapeutics, 9th Edition J.G Hardman, L.E. Limbird, P.B. Molinoff, R.W, Ruddon and A.G. Gilman (eds.), McGrawHill, New York, USA, pp. 617-657 (1996)
  2. H.S. Gwak and I.K. Chun, Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin, Int. J. Pharm., 236, 57-64 (2002) https://doi.org/10.1016/S0378-5173(02)00009-1
  3. J.A Cordero, L. Alarcon, E. Escribano, R. Obach and J. Domenech, A comparative study of the transdermal penetration of a series of nonsteroidal anti-inflammatory drugs, J. Pharm. Sci., 86, 503-508 (1997) https://doi.org/10.1021/js950346l
  4. H.-A. Cheong and H.-K. Choi, Enhanced percutaneous absorption of piroxicam via salt formation with ethanolamines, Pharm. Res., 19, 1375-1380 (2002) https://doi.org/10.1023/A:1020367212307
  5. S.A. Megwa, S.E. Cross, M.W. Whitehouse, H.A.E. Benson and M.S. Roberts, Effect of ion pairing with alkylamines on the in-vitro dermal penetration and local tissue disposition of salicylates, J. Pharm. Pharmacol., 52, 929-940 (2000) https://doi.org/10.1211/0022357001774813
  6. C. Valenta, U. Siman, M. Kratzel and J. Hadgraft, The dermal delivery of lignocaine: Influence of ion pairing, Int. J. Pharm., 197, 77-85 (2000) https://doi.org/10.1016/S0378-5173(99)00453-6
  7. T. Hatanaka, T. Kamon, S. Morigaki, K. Katayama and T. Koizumi, Ion pair skin transport of a zwitterionic drug, cephalexin, J. Control. Release, 66, 63-71 (2000) https://doi.org/10.1016/S0168-3659(99)00259-X
  8. G. Engelhardt, R. Bogel, C. Schnitzler and R. Utzmann, Meloxicam: Influence on arachidonic acid metabolism, Biochem. Pharmacol., 51, 29-38 (1996) https://doi.org/10.1016/0006-2952(95)02110-8
  9. Y.-J. Cho and H.-K. Choi, Enhancement of percutaneous absorption of ketoprofen: Effect of vehicles and adhesive matrix, Int. J. Pharm., 169, 95-104 (1998) https://doi.org/10.1016/S0378-5173(98)00115-X
  10. S. Defazio and R. Cini, Synthesis, X-ray structural characterization and solution studies of metal complexes containing the anti-inflammatory drugs meloxicam and tenoxicam, Polyhedron, 22, 1355-1366 (2003) https://doi.org/10.1016/S0277-5387(03)00112-8
  11. G.C. Mazzenga and B. Berner, The transdermal delivery of zwitterionic drugs II: The solubility of zwitterions salts, J. Control. Release, 16, 77-88 (1991) https://doi.org/10.1016/0168-3659(91)90032-9
  12. K. Takayashi, H. Sakano, M. Yoshida, N. Numata and N. Mizuno, Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin, J. Control. Release, 73, 351-358 (2001) https://doi.org/10.1016/S0168-3659(01)00359-5
  13. M. Endo, T. Yamamoto and T. Ijuin, Effect of nonionic surfactants on the percutaneous absorption of tenoxicam, Chem. Pharm. Bull., 44, 865-867 (1996) https://doi.org/10.1248/cpb.44.865
  14. E.-S. Park, S.-Y. Chang, M. Hahn and S.-C. Chi, Enhancing effect of polyoxyethylene alkyl ethers on the skin permeation of ibuprofen, Int. J. Pharm., 209, 109-119 (2000) https://doi.org/10.1016/S0378-5173(00)00559-7